Veteran driver Charlie Kimball is returning to full-time competition in the NTT INDYCAR SERIES, joining AJ Foyt Racing as the driver of the No. 4 Chevrolet sponsored by Novo Nordisk.
The upcoming season will mark Kimball’s 10th consecutive year in the series and his 12th season of partnership with the global healthcare company.
Kimball, who ran seven of the 17 races in 2019, will carry a Novo Nordisk branded livery in seven races, including the season-opening Firestone Grand Prix of St. Petersburg. That first race of the year is March 13-15.
Novo Nordisk also will be the primary sponsor of Kimball’s car in Long Beach, the Indianapolis road race, Texas, World Wide Technology Raceway at Gateway and WeatherTech Raceway Laguna Seca. Novo Nordisk will be an associate marketing partner in the remaining 11 races.
“I’m excited and honored to join AJ Foyt Racing and be a part of a team that has such deep roots in history at the Indianapolis Motor Speedway and IndyCar,” said Kimball, who lives in Indianapolis. “Continuing the partnership with Novo Nordisk is also special since they have been an integral part of my career since I was diagnosed with Type 1 diabetes. I’m more motivated than ever to work with the team to succeed at every IndyCar race in 2020. Thank you to AJ Foyt Racing, Novo Nordisk and our other partners for this opportunity.”
The race team has not announced plans for the No. 14 car.
Team President Larry Foyt expects the partnership with Novo Nordisk and the addition of Charlie Kimball, an NTT INDYCAR SERIES race winner at the Mid-Ohio Sports Car Course (2013) and a pole winner at Texas Motor Speedway (2017), to invigorate his No. 4 Texas-based team this season.
“Charlie brings a great deal of experience and skill to the team,” Foyt said. “He is motivated to show what he can do behind the wheel, and his recent experience of helping develop cars will be beneficial as we work to get the 4 car moving up the grid. Novo Nordisk has been a long-time supporter of Charlie and IndyCar. We want to welcome them to AJ Foyt Racing and we look forward to joining them in their effort to increase the awareness of diabetes.”
Kimball has posted six podium (top-three) finishes and an additional eight top-fives. He has led 163 laps in 141 races.
“We are proud to continue our long-term partnership with Charlie Kimball and look forward to an exciting 2020 IndyCar season with the legendary AJ Foyt Racing,” said Brian Hilberdink, Senior Vice President, Commercial Diabetes at Novo Nordisk. “For more than a decade, we’ve utilized our involvement in IndyCar to share Charlie’s inspiring journey living with diabetes through the Race with Insulin initiative. Charlie is one of the most active ambassadors in the diabetes community and his passion and commitment to making a difference in the lives of those who are living with diabetes is unwavering. We look forward to continuing this tradition with AJ Foyt Racing, Charlie and the diabetes community throughout the IndyCar season.”
Foyt expects to make further announcements regarding new primary sponsors for the team in the near future.